Aβ	amyloid-beta
Aβ42/Aβ40	ratio of Aβ42 to Aβ40
AD	Alzheimer’s disease
APP	amyloid precursor protein
AUC	area under the curve
BMI	body mass index
CERAD	Consortium to Establish a Registry for Alzheimer’s Disease
CKD	chronic kidney disease
CLEIA	chemiluminescent enzyme immunoassay
CSF	cerebrospinal fluid
CU	cognitively unimpaired
ELISA	enzyme-linked immunosorbent assay
EV	extracellular vesicle
FTD	frontotemporal dementia
GVB	granulovacuolar body
lvPPA	logopenic variant primary progressive aphasia
MCI-AD	mild cognitive impairment due to AD
MI	myocardial infarction
nbM	nucleus basalis of Meynert
NfL	neurofilament light chain
PCA	posterior cortical atrophy
PET	positron emission tomography
p-tau	phosphorylated tau
p-tau217	phosphorylated tau at threonine 217
p/t-tau	p-tau to t-tau ratio
pT217/T217	ratio of phosphorylated to unphosphorylated tau
t-tau	total tau